# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $...
B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $...
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $99 to $92.
Piper Sandler analyst Michael Lavery assumes Colgate-Palmolive (NYSE:CL) with a Neutral rating and announces Price Target of...
Goldman Sachs analyst Jason English maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $106 t...
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from...
8 analysts have expressed a variety of opinions on Colgate-Palmolive (NYSE: CL) over the past quarter, offering a diverse set o...